Mr. Schwarzer has served as our Chief Executive Officer and a member of our Board since 2010. Mr. Schwarzer was a Managing Partner of Charter Life Sciences, a venture capital firm specializing in life sciences investments, for approximately 15 years. He also served as Chair of Inviragen, the creators of the DENVax dengue vaccine, from the time of its first venture capital financing until its acquisition by Takeda. Mr. Schwarzer previously served as Chief Executive Officer and then Chair of the Board of Directors of Heska Corporation, a biotechnology company. Mr. Schwarzer received a B.A. in Pre-Legal Studies from the University of Michigan and a J.D. from the University of California, Berkeley, School of Law.
Fred M. Schwarzer